HIGHLIGHTS
- who: BDDD- and collaborators from the Department of Neurosurgery, Gusu School, Nanjing Medical University, The First People`s Hospital of Kunshan, Suzhou, China have published the Article: Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway, in the Journal: (JOURNAL)
- what: In present study, the authors investigated the cytotoxic effects of curcumin and BDDD-721 against medulloblastoma cells by using MTT assay . In this study, a novel analog of curcumin bearing N atom was designed and prepared to improve the drug likeness of curcumin following . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.